title: Switching to once-daily liraglutide from twice-daily exenatide further improves glycemic control in patients with type 2 diabetes using oral agents.
authors.affiliation: Division of Endocrinology, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA. jbuse@med.unc.edu
authors.forename: John B
authors.initials: JB
authors.lastname: Buse
authors.forename: Giorgio
authors.initials: G
authors.lastname: Sesti
authors.forename: Wolfgang E
authors.initials: WE
authors.lastname: Schmidt
authors.forename: Eduard
authors.initials: E
authors.lastname: Montanya
authors.forename: Cheng-Tao
authors.initials: CT
authors.lastname: Chang
authors.forename: Yizhen
authors.initials: Y
authors.lastname: Xu
authors.forename: Lawrence
authors.initials: L
authors.lastname: Blonde
authors.forename: Julio
authors.initials: J
authors.lastname: Rosenstock